1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
BRT Apartments Corp. amended its loan agreement with VNB New York, LLC, lowering the facility's interest rate and minimum rate and the cap rate used to value secured assets. The company also said its board replenished its stock repurchase program to $10 million, and as of September 17, 2026, it can borrow $40 million under the facility.
Interest rate cut to three-month term SOFR plus 210 basis points, from plus 250 basis points
Minimum interest rate reduced to 5%, from 6%; asset valuation cap rate reduced to 6.25%, from 6.5%
Board increased stock repurchase program value to $10 million on September 17, 2026
Borrowing availability under the facility is $40 million as of September 17, 2026
Amerant Bancorp completed a $50 million offering of 7.00% Senior Notes due September 17, 2031, with net proceeds of approximately $48.4 million. The company plans to use the proceeds for general corporate purposes, including supporting Amerant Bank, N.A., repaying debt and repurchasing Class A common stock.
$50 million aggregate principal of 7.00% Senior Notes due September 17, 2031, sold under a shelf registration filed June 12, 2026
Net proceeds of approximately $48.4 million after the underwriter's discount and offering expenses
Interest paid semi-annually on March 17 and September 17, starting March 17, 2027
Offering closed September 17, 2026; Raymond James & Associates was sole book-running manager
First Financial Corporation said Chief Financial Officer Rodger A. McHargue will retire effective December 31, 2026, and its Board appointed Senior Vice President and Director of Finance Paul D. Nungester, Jr. to succeed him effective January 1, 2027. The filing also describes Nungester's employment agreement, which includes a $375,000 base salary and severance terms tied to a change in control.
McHargue, who has served as CFO since 2010, retires effective December 31, 2026.
Nungester, age 52, joined the company on August 10, 2026 and becomes CFO effective January 1, 2027.
Nungester's employment agreement runs through June 30, 2028 and sets a base salary of $375,000 per year.
Change-in-control severance equals 2.0 times the sum of base salary, prior-year bonuses and benefit reimbursements.
Upexi reported results for the fiscal year ended June 30, 2026, in a press release furnished as Exhibit 99.1. Total revenue rose to about $25.0 million from $15.8 million, but the net loss grew to $246.1 million, or $3.87 per share, from $13.7 million, or $1.73 per share, mainly due to $195.1 million of unrealized losses on digital assets, so shareholders face a much larger reported loss despite higher revenue.
Total revenue was about $25.0 million for fiscal 2026, compared with $15.8 million for fiscal 2025; digital asset revenue totaled $17.4 million.
Net loss was $246.1 million, or $3.87 per share, versus $13.7 million, or $1.73 per share, a year earlier, driven by $195.1 million of unrealized losses on digital assets.
General and administrative expenses rose to $26.4 million from $11.9 million, primarily reflecting the build-out of the treasury strategy.
Subsequent to year-end, the credit facility with BitGo Prime, LLC was amended to reduce the interest rate from 11.5% to 7.5% per year.
Anteris Technologies approved contingent equity awards for CEO Wayne Paterson, David St Denis and Matthew McDonnell, including options and performance-based restricted stock units. The grants take effect only if stockholders approve them, and the PSUs vest only if the stock reaches price hurdles of $21.50, $41.00 and $61.50 over a five-year period.
Paterson receives 1,200,000 options and 800,000 PSUs; St Denis receives 414,000 options and 485,000 PSUs
McDonnell receives options with a target value of $500,000, vesting over three years
Grants have a grant date of September 13, 2026, and are contingent on stockholder approval
CO2 Energy Transition Corp. said its non-binding letter of intent for an initial business combination expired after the parties chose not to extend the September 14, 2026 deadline for a definitive agreement. Nasdaq also approved moving the company's units, warrants, rights and common stock from the Nasdaq Global Market to the Nasdaq Capital Market, effective September 16, 2026. The company said it continues talks with the other party and is evaluating other opportunities.
Non-binding letter of intent, announced July 17, 2026, expired after the parties did not extend the September 14, 2026 deadline
Company continues discussions with the other party and is evaluating other potential business combinations
Nasdaq approved transfer to the Nasdaq Capital Market on September 14, 2026; transfer effective at market open September 16, 2026
GMR Solutions' subsidiary GMR, Inc. amended its first lien term loan on September 17, 2026, lowering the interest margin from SOFR +3.25% to SOFR +2.75% and prepaying about $200 million with cash on hand. The company estimates the change will save about $28 million a year in cash interest expense, and the filing says pro forma cash would have been about $188 million, with total debt of about $4.27 billion, based on its June 30, 2026 balance sheet.
Voluntary prepayment of about $200 million of first lien term loans, using cash on hand, cutting principal to about $2.7 billion
Interest margin over SOFR reduced from +3.25% to +2.75%, a cut of about 50 basis points
Company estimates about $28 million of annual cash interest expense savings
About $32 million of cash paid on September 14, 2026 for payroll taxes on settled equity awards
At the September 16, 2026 annual meeting, Methode Electronics stockholders approved the 2026 Omnibus Incentive Plan and elected seven directors, but director David P. Blom received fewer votes for than against. The Board rejected Mr. Blom's conditional resignation, so he will continue to serve until the 2027 annual meeting. Stockholders also ratified Ernst & Young LLP as the independent auditor and approved executive pay in an advisory vote.
2026 Omnibus Incentive Plan approved: 27,466,037 for and 812,903 against
David P. Blom received 7,050,790 for and 21,241,811 against, short of a majority, so he tendered a conditional resignation
Board rejected Mr. Blom's resignation; he stays on the Board until the 2027 annual meeting
Say-on-Pay approved with 24,802,391 for and 3,471,604 against
Ellington Financial Inc. closed a private offering of $150 million in additional 7.375% senior unsecured notes due September 30, 2030, issued as add-on notes to its existing $400 million series. The company said it expects to use the proceeds for general corporate purposes, including repaying part of its repurchase agreement borrowings and buying more assets, which adds long-term unsecured debt to its balance sheet.
Notes issued at 99.010% of principal amount, with a yield to maturity of 7.663%
Notes mature September 30, 2030 and pay 7.375% interest semi-annually; first payment September 30, 2026
Proceeds to be used for general corporate purposes, including repaying part of repurchase agreement borrowings
Notes are unsecured and guaranteed by the parent, and carry a 1.20 to 1.0 unencumbered asset covenant
Hub Group said Nasdaq issued a Staff Delisting Determination on September 16, 2026, because the company has not filed its 2025 Form 10-K or its Forms 10-Q for the quarters ended March 31 and June 30, 2026. The company intends to appeal to a Nasdaq Hearings Panel and to seek an extended stay, but the filing says there is no assurance the stay will be granted, and the determination could lead to trading suspension.
Nasdaq issued the Staff Determination on September 16, 2026, after the filing deadline of September 14, 2026, the last day of a 180-day extension.
The determination has no immediate effect on trading, but a hearing request must be made by September 23, 2026.
A hearing request automatically stays suspension for 15 days; if the Hearings Panel does not grant a further stay, Class A common stock would be suspended at the end of that period.
Hearings are typically scheduled about 30 to 45 days after the hearing request.
KIDZ AI completed an additional closing under its May 2025 securities purchase agreement, issuing a $1.9 million senior secured convertible note to Solana Growth Ventures LLC. The note carries 7% interest, matures September 17, 2028, and converts into Class B common stock at an initial price of $3.672 per share, which adds debt and potential dilution for existing shareholders.
Principal amount of the Additional Note is $1,900,000, with funding net of placement agent fees and offering expenses
Interest is 7% per annum, payable quarterly in cash, added to principal, or in shares
Note matures September 17, 2028 and ranks senior to outstanding and future indebtedness, secured by a first priority interest
Initial conversion price is $3.672 per share of Class B common stock
Phoenix Education Partners, Inc. (PXED) agreed on September 16, 2026 to acquire Fuel50 Inc., an AI-powered workforce transformation platform, for an aggregate cash purchase price of approximately $31.5 million, plus earnout payments of up to $8.5 million through calendar year 2027. The deal is funded with cash on hand and is expected to close within 30 days, subject to Fuel50 stockholder approvals and other closing conditions. The filing does not include Fuel50's financial results, so its effect on Phoenix Education's earnings is not disclosed.
Aggregate cash purchase price of approximately $31.5 million, subject to customary adjustments for working capital, cash, indebtedness and transaction expenses
Earnout payments of up to $8.5 million in aggregate through calendar year 2027, based on performance milestones
Funded with cash on hand; expected to close within 30 days, subject to Fuel50 stockholder approvals and other conditions
Fuel50 will operate under its own brand; Jo Mills, Co-founder and President of Fuel50, is expected to become its Chief Executive Officer after closing
Rexford Industrial completed the $1.2 billion sale of a 22-property industrial portfolio to an affiliate of EQT Real Estate on September 16, 2026. The company said the deal is part of a $2.0 billion non-core disposition program and that it reaffirmed its 2026 guidance, which does not show a change in direction for headline results.
Portfolio of 22 industrial properties totaling 5.2 million rentable square feet sold for approximately $1.2 billion before credits, prorations and closing adjustments
Year-to-date dispositions total $1.5 billion, within the full-year 2026 disposition guidance range of $1.5 billion to $2.0 billion
Quarter to date, $485 million of debt repaid and $205 million of common stock repurchased; company reaffirmed 2026 guidance from its July 23, 2026 earnings release
Piedmont Operating Partnership, a subsidiary of Piedmont Realty Trust, issued $230 million of 2.875% Exchangeable Senior Notes due February 1, 2031, guaranteed by the company. The company said it intends to use the proceeds, along with other sources, to redeem its 9.250% senior notes due 2028, and it used about $50 million of proceeds to repurchase 5,434,782 common shares from certain note purchasers. Holders can exchange the notes for cash or a mix of cash and common stock at an initial price of about $12.65 per share, so the deal could affect the share count if exchanged.
$230 million principal issued September 17, 2026, including $30 million of option notes
Notes bear 2.875% interest, payable semi-annually from February 1, 2027, and mature February 1, 2031
Initial exchange price is about $12.65 per share, equal to 79.0514 shares per $1,000 principal
About $50 million of proceeds used to repurchase 5,434,782 common shares from certain note purchasers
Burford Capital's subsidiary Burford Capital Global Finance LLC closed a $300 million private offering of 8.000% senior secured notes due October 15, 2029, guaranteed by Burford Capital. The company said it intends to use the proceeds, with cash on hand, to fully redeem its 6.250% senior notes due 2028, and the indenture restricts certain debt, dividends, liens and asset sales.
Offering size: $300 million aggregate principal amount of 8.000% senior secured notes due October 15, 2029, closed September 17, 2026
Proceeds, plus cash on hand, intended to redeem in full the 6.250% senior notes due 2028
Interest payable semi-annually on April 15 and October 15, starting April 15, 2027
Change of control triggers an offer to repurchase at 101% of principal, plus accrued interest
Janus Living and its operating company amended and restated their Original Credit Agreement with Bank of America, N.A. as administrative agent, effective September 17, 2026. The revolving credit facility rises from $500 million to $1.25 billion, and the $100 million delayed draw term loan facility is terminated. The filing says the terms are otherwise generally consistent with the original agreement.
Revolving credit facility increases from $500 million to $1.25 billion.
Company can increase the revolver and/or add incremental term loans up to an aggregate $1.75 billion, subject to customary requirements including additional lender commitments.
$100 million delayed draw term loan facility outstanding under the original agreement is terminated.
Original Credit Agreement was dated March 23, 2026; the amended agreement is dated September 17, 2026.
Pathward Financial said President Anthony Sharett resigned from his roles as President of the company and of its subsidiary Pathward, N.A., to pursue other opportunities. The company plans to implement its succession plan and reorganize the President's responsibilities among existing executives.
Sharett notified the company of his resignation on September 14, 2026; it takes effect October 23, 2026.
The company intends to implement its succession plan; no successor is named in the filing.
Sharett previously served as chief legal and compliance officer, general counsel and corporate secretary.
Analog Devices sold $3 billion of unsecured senior notes in four tranches maturing between 2029 and 2036, under an underwriting agreement dated September 15, 2026. The notes carry fixed rates from 5.100% to 5.750% and are not guaranteed by subsidiaries, so the debt adds to the company's borrowings at these rates.
Four tranches: $500 million due September 15, 2029 (5.100%); $500 million due October 1, 2031 (5.350%); $1 billion due October 1, 2033 (5.600%); $1 billion due October 1, 2036 (5.750%)
Notes were issued September 17, 2026 under an effective Form S-3 shelf registration and sold in an underwritten public offering led by J.P. Morgan Securities LLC
Company may redeem each series before its par call date at the greater of a make-whole price or 100% of principal, and at 100% of principal afterward
Enova International's subsidiary HWC Receivables 2023, LLC amended its existing revolving receivables facility on September 17, 2026, through an Omnibus Amendment with lenders and other parties. The filing lists a total facility commitment of $535 million, with Class A and Class B revolving loans carrying adjusted SOFR-based borrowing rates and a maturity date of March 2029. The filing does not compare these terms with the prior facility, so the effect on shareholders is not stated.
Total facility commitment is $535 million: $400 million Class A and $135 million Class B revolving loans
Borrowing rates are SOFR + 2.75% for Class A, SOFR + 8.50% for Class B, and SOFR + 4.20% total
Revolving period ends March 2028; maturity date is March 2029
Full Credit Agreement, as amended, will be filed with the Form 10-Q for the quarter ending September 30, 2026
Faeth Therapeutics appointed Karen Vousden, Ph.D., a cancer biologist and company co-founder, as a Class II director effective immediately, after increasing the board from five to six seats. She also joined the Compensation Committee, and will receive a 25,000-share stock option under the company's director compensation program.
Board expanded from five to six directors on September 11, 2026.
Dr. Vousden's term runs until the 2029 annual meeting of stockholders.
Initial grant is an option to purchase 25,000 shares of common stock, vesting monthly through the third anniversary of the grant date.
Dr. Vousden is a Principal Group Leader at The Francis Crick Institute and a director of Bristol Myers Squibb Company since 2018.
Loop Industries said its Board of Directors has formed a Strategic Alternatives Committee, following the appointment of Jeff Geygan as Chairman and the separation of the Chairman and CEO roles. The committee's immediate priority is securing the capital contribution and project-financing structure for the planned India joint venture, and it will evaluate options that include a potential sale, merger or going-private transaction. The company said no decision has been made, no timetable has been set, and there is no assurance the review will lead to any transaction.
The Board formed the Strategic Alternatives Committee, announced in a press release dated September 17, 2026.
The immediate priority is securing Loop's required capital contribution for the India joint venture through project-level debt, strategic capital, equity financing or a combination.
Options under review include strategic investments, licensing, regional joint ventures, business combinations, and a potential sale, merger or going-private transaction.
No specific alternative has been chosen and no timetable has been established; the company does not intend to comment further unless the Board approves a specific course of action.
Texas Instruments said it will raise its quarterly cash dividend 7%, from $1.42 to $1.52 per share, or $6.08 annualized. The higher dividend is payable November 10, 2026, to holders of record on October 30, 2026, and is contingent on board declaration at its October regular meeting. The filing says the increase marks 23 consecutive years of dividend increases and reflects the company's commitment to return all free cash flow to owners over time.
Quarterly dividend rises 7%, from $1.42 to $1.52 per share
Annualized dividend is $6.08 per share
Payable November 10, 2026, to stockholders of record on October 30, 2026
Requires formal declaration by the board at its regular October meeting
Expand Energy Corporation completed its underwritten public offering of $500 million in 5.650% senior notes due 2031 on September 17, 2026. The notes are unsecured and rank equally with the company's other senior unsecured debt, but they are not guaranteed by its subsidiaries, which leaves them structurally subordinated to subsidiary debt.
Principal amount: $500 million of 5.650% Senior Notes due 2031, issued September 17, 2026
Notes are senior unsecured obligations of Expand Energy, not guaranteed by subsidiaries
Optional redemption before August 15, 2031 at a make-whole price; at or after that date at 100% of principal plus accrued interest
Regions Bank is trustee under the base indenture dated December 2, 2024, as supplemented
Paylocity entered into an amended and restated $1.75 billion senior secured revolving credit facility with PNC Bank, National Association, as administrative agent, replacing its 2019 credit agreement as amended in 2022 and 2024. As of the effective date, $81.25 million was outstanding, and the facility matures on September 17, 2031.
$1.75 billion senior secured revolving facility, maturing September 17, 2031
$81.25 million outstanding under the facility as of September 17, 2026
Company may request up to $875.0 million in increased commitments; lenders are not obligated to provide them
Covenants require a maximum net total leverage ratio of 4.00 to 1.00 and a minimum interest coverage ratio of 2.00 to 1.00
Axe Compute agreed on September 11, 2026 to sell Helomics, its last operating business from its former identity as Predictive Oncology, to DataMeds AI (NASDAQ: MEDS). The sale closed the same day, and the company received DataMeds stock and a convertible note rather than cash. The filing says the sale completes Axe Compute's transition to a pure-play neocloud GPU-as-a-Service company.
Consideration: 636,328 DataMeds common shares, equal to 19.99% of DataMeds shares outstanding before closing, plus a $1,363,672 convertible note with a $1.00 per share conversion price.
The shares and conversion shares are restricted securities subject to a 12-month lock-up from the closing date.
Axe Compute must pay the remaining base rent on two Pittsburgh, Pennsylvania leases used by Helomics through the current lease terms; other lease costs fall to DataMeds and Helomics.
The company issued a press release on September 15, 2026 announcing completion of the sale.
Fennec Pharmaceuticals said detailed results from the investigator-initiated Phase 2 STS-J01 study of PEDMARK in Japan met the primary endpoint, with hearing loss in 24.0% of patients versus a prespecified historical benchmark of 56.4%. The data were presented orally on September 17, 2026, at the 58th SIOP Annual Meeting, and the company said it is pursuing registration in Japan and exploring partnering or licensing options.
Primary endpoint met: ASHA-defined hearing loss in 24.0% (6 of 25) versus a prespecified historical benchmark of 56.4% (P=0.001)
84.0% of patients had Grade 0 hearing loss by Brock criteria; no Grade 3 or Grade 4 hearing loss was observed
Objective tumor responses in 23 of 24 evaluable patients (95.8%)
Results presented at the 58th SIOP Annual Meeting in San Antonio, TX; Fennec is pursuing registration in Japan and exploring partnering or licensing for PEDMARK
LCNB Corp. said its EVP and Chief Wealth Officer, Michael R. Miller, will retire from the company and LCNB National Bank effective March 31, 2027. Joshua A. Shapiro has been promoted to Director of LCNB Wealth, and Bradley A. Ruppert will oversee the Wealth Group after Miller leaves, which the company says provides continuity for clients.
Michael R. Miller, EVP and Chief Wealth Officer, retires effective March 31, 2027
Under Miller, LCNB Wealth assets under management rose from approximately $457 million at year-end 2016 to approximately $1.68 billion at June 30, 2026
Joshua A. Shapiro promoted to Director of LCNB Wealth; takes day-to-day responsibility effective January 1, 2027, reporting to Bradley A. Ruppert
Nasdaq notified Fifth Era Acquisition Corp I on September 14, 2026 that it does not meet the 400 Total Holders requirement for continued listing on the Nasdaq Global Market. Nasdaq says this is a deficiency notice, not an imminent delisting, and the listing and trading of the company's securities are not currently affected.
Nasdaq Listing Rule 5450(a)(2) requires at least 400 Total Holders for continued listing on the Nasdaq Global Market
The company has until October 29, 2026 to submit a plan to regain compliance
If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days from the date of the notice
The company may consider transferring its securities to The Nasdaq Capital Market
Azenta's board approved a letter agreement with Dr. Martin D. Madaus, its Interim President and Chief Executive Officer since August 22, 2026, setting his base salary, a cash performance bonus, and an equity grant. The company also granted retention restricted stock units to four named executive officers, including $1,000,000 for Chief Financial Officer Lawrence Lin. The filing discloses pay terms and governance changes, and it does not report financial results.
Madaus receives an annual base salary of $600,000 and a cash performance recognition bonus equal to 100% of salary, which vests on the first anniversary of his start date.
Madaus receives restricted stock units with an award value of $1,200,000, vesting in 1/12 monthly installments from his start date.
Retention awards: Lawrence Lin $1,000,000; Ephraim Starr, Olga Pirogova and Trey Martin $500,000 each, with 50% vesting on each of the first and second anniversaries of the September 14, 2026 grant date.
Madaus left the Nominating and Governance Committee, which now consists of William L. Cornog (Chair), Frank E. Casal and Robyn C. Davis.
PBF Holding Company LLC, a subsidiary of PBF Energy Inc., issued $550.0 million of 0% Exchangeable Senior Notes due 2032 in a private placement under Rule 144A, including $50 million from the initial purchasers' option. The Issuers expect net proceeds of approximately $533.6 million, to be used for capped call transactions, redeeming the 7.875% senior notes due 2030, and general corporate purposes, and the notes can be exchanged into PBF Energy Class A common stock at an initial exchange price of about $96.80 per share.
Principal amount: $550.0 million, maturing January 15, 2032; the notes do not bear regular interest
Estimated net proceeds: approximately $533.6 million after discounts and estimated offering expenses
Proceeds fund capped call costs, full redemption of the 7.875% senior notes due 2030, and general corporate purposes
PBF Energy agreed to file a shelf or resale registration statement covering shares issuable on exchange by December 31, 2026
Lisata Therapeutics acquired Marea Therapeutics on September 17, 2026, issuing 1,793,129 shares of common stock and 211,365.213 shares of Series C convertible preferred stock to Marea stockholders. A concurrent private placement is expected to raise about $225 million in gross proceeds, and the filing says pre-transaction Lisata stockholders will hold about 2.39% of the company's common stock after the financing, which substantially dilutes existing holders.
Lisata issued 1,793,129 common shares and 211,365.213 Series C preferred shares to Marea stockholders; each preferred share converts into 1,000 common shares, subject to Lisata stockholder approval
Concurrent private placement with a gross value of about $225 million; the investors will receive Series C preferred shares at about $1,491.37 per share
Post-financing ownership: pre-transaction Lisata holders about 2.39%, former Marea holders about 59.54%, private placement investors about 38.07%
Lisata's CEO is Dr. David J. Mazzo; Dr. Josh Lehrer was newly appointed President and Chief Operating Officer of Lisata
Two Caesars directors, Jesse Lynn and Ted Papapostolou, resigned from the board effective immediately on September 16, 2026, and the Icahn Group waived its right to appoint replacements. The Federal Trade Commission issued a Second Request on September 14, 2026, which extends the HSR Act waiting period for the pending merger with Fertitta Entertainment, so completion is further delayed and remains subject to regulatory review and other closing conditions.
Jesse Lynn and Ted Papapostolou resigned from the board effective immediately, as of September 16, 2026.
The Icahn Group waived its right to appoint replacement directors under the agreement dated March 17, 2025.
The FTC issued a Second Request on September 14, 2026; the waiting period runs until 30 days after substantial compliance by each party, unless extended or ended sooner.
The proxy deadline for internet or telephone voting is 11:59 p.m. Eastern Time on September 21, 2026.
PetMed Express (PetMeds) appointed Jeff Willard as Chief Executive Officer, President and a director, effective September 28, 2026, succeeding Leslie C.G. Campbell, who has served as Interim CEO and President since August 2025. Campbell is also retiring as Board Chair and leaving the Board on the same date, and Justin Mennen will become Chair. The filing sets Willard's initial base salary at $550,000 and a three-year initial employment term, a significant change in the company's top leadership.
Jeff Willard, age 56, was CEO of Stewart-MacDonald from November 2024 to September 2026; the Board approved his appointment on August 27, 2026.
Initial base salary of $550,000, target annual bonus of 75% of base salary, and a $120,000 signing bonus.
Justin Mennen, currently Lead Independent Director, succeeds Leslie C.G. Campbell as Chair effective September 28, 2026.
Campbell will remain as a full-time Strategic Advisor for 60 days following Willard's arrival.
Surgery Partners completed the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health on September 14, 2026, receiving aggregate consideration of about $796.6 million, with proceeds mainly used to pay down debt. Pro forma figures show lower revenue and a larger net loss attributable to the company for the periods presented, while management expects the deal to be accretive to adjusted earnings growth on an annual basis and to reduce balance sheet leverage. The company also updated its 2026 guidance to remove the sold hospitals' contribution for the rest of the year.
Sale closed September 14, 2026; gross proceeds of $797 million and $587 million in net cash proceeds at closing, subject to post-closing adjustments.
Balance sheet leverage, as defined in the credit agreement, is expected to improve by 30 basis points from 4.4x at the end of Q2 2026.
Updated 2026 guidance: revenue of $3.08 billion to $3.18 billion and Adjusted EBITDA of at least $489 million.
Pro forma net loss attributable to Surgery Partners was $69.2 million for the six months ended June 30, 2026, versus $50.9 million as reported; estimated gain on sale is $16.4 million.
Eightco Holdings (NASDAQ: ORBS) said its treasury holdings totaled approximately $380 million as of September 16, 2026, spanning indirect OpenAI and Beast Industries stakes, WLD and ETH tokens, and cash. The company also said it has repurchased over 26 million shares this quarter under its $125 million share repurchase program. The release is a holdings update and does not report revenue, profit, or guidance.
As of September 16, 2026, 4:30 p.m. ET: $90 million indirect investment in OpenAI through SPVs and $18 million funded investment in Beast Industries
Holds 301,971,219 WLD at $0.37 per WLD (per Coinbase) and 16,278 ETH
Approximately $120 million in total cash and stablecoins
Repurchased over 26 million shares this quarter under the previously announced $125 million program
Franklin BSP Realty Trust's board reappointed Richard Byrne as Chief Executive Officer effective September 16, 2026, succeeding Michael Comparato, who resigned on September 15, 2026. The company said Comparato is stepping back from day-to-day executive responsibilities, and Byrne will also remain Chairman of the Board. For shareholders, this is a change in the company's top executive role at an externally managed real estate investment trust.
Richard Byrne reappointed CEO effective September 16, 2026; he previously served as CEO from 2016 to February 2026 and continues as Chairman.
Michael Comparato resigned as CEO on September 15, 2026, and will serve as an advisor to Benefit Street Partners L.L.C.; the press release describes a Senior Advisor role at BSP through 2027.
Jerome S. Baglien, CFO and COO, was appointed Co-President alongside Brian Buffone and will lead BSP's Commercial Real Estate Debt platform.
Duke Robotics appointed Avi Levin as Chief Financial Officer, effective October 1, 2026, replacing Shlomo Zakai, who will continue to provide consulting services to the company. The filing sets out Levin's pay, which includes a monthly base salary and a future grant of stock options, so shareholders can see the compensation terms tied to the new finance chief.
Avi Levin becomes CFO on October 1, 2026; Shlomo Zakai ceases to be CFO at that time and is expected to continue as a financial and corporate consultant.
Levin's gross monthly base salary is NIS 52,250 (approximately $17,227), with a gross monthly expense allowance of NIS 2,500 (approximately $824).
The Board approved a future grant of options to buy up to 35,000 shares, with a six-year term and a strike price equal to the average closing price over the 30 trading days before the grant date.
Levin previously served as CFO of RAD Data Communications (2023 to 2025), BlackSwan Technologies (2021 to 2023) and Ability Inc. (2015 to 2020).
Colony Bankcorp said on September 17, 2026 that it has received all required regulatory approvals for its merger with First Reliance Bancshares. The deal still needs shareholder approvals from both companies, with special meetings set for October 14, 2026, and the 8-K gives an expected closing date of November 1, 2026.
All required regulatory approvals received, announced September 17, 2026
Shareholder special meetings for both companies scheduled for October 14, 2026
Expected closing date of November 1, 2026, pending shareholder approvals and other customary conditions
Deal valued at approximately $163 million; combined company to have about $5 billion in total assets
World Kinect said Michael J. Kasbar will step down as Executive Chairman effective December 31, 2026, and will remain a member of the Board. Director Ken Bakshi, who has served on the Board since 2002, was appointed independent Chair effective the same date. The company says the Board believes an independent chair strengthens its oversight, and the filing states the departure was not due to any disagreement with the company.
Kasbar steps down as Executive Chairman effective December 31, 2026, and continues as a Board member.
Ken Bakshi, on the Board since 2002, is appointed independent Chair effective December 31, 2026.
Kasbar's employment agreement expired December 31, 2025; severance payments and benefits became payable but were not paid while he remained employed, subject to restrictive covenants for two years after he leaves the Executive Chairman role
The filing states the step-down was not the result of any disagreement with the company on operations, practices or policies.
On September 15, 2026, Hallador Energy and subsidiary Turtle Creek Gas Holdings closed a $600 million senior secured term loan with Kennedy Lewis Investment Management, with $550 million funded at closing. The company says the loan will fund turbine payments, development costs and construction of the 460-megawatt Turtle Creek gas project, which has an expected total cost of less than $800 million, but borrowings carry high interest rates and are secured by substantially all company and subsidiary assets.
$600 million senior secured term loan, with $550 million funded at closing and a $50 million delayed draw available for 12 months
Interest is 3.5% cash plus SOFR plus 4.50% payable in kind before commercial operation, then SOFR plus 8.00% in cash after operation begins
Loan matures three years after closing, with a two-year extension option requiring a 3.0% extension fee
Covenants include minimum unrestricted cash of $10 million starting with the test period ending December 31, 2026
Aethlon Medical and private biotech North Immunology signed a merger agreement in which North Immunology becomes a wholly owned subsidiary of Aethlon and the combined company is renamed North Immunology, Inc. Pre-merger Aethlon stockholders are expected to own about 4.75% of the combined company, while Aethlon stockholders also receive contingent value rights tied to proceeds, if any, from a sale or other monetization of its legacy Hemopurifier business.
Pre-merger Aethlon stockholders are expected to own about 4.75% of the combined company; North Immunology holders, including Private Placement investors, about 95.25%
Concurrent private placement expected to provide about $180 million, including about $34 million from converted notes; closing requires at least $175 million in proceeds
Expected to close in the first quarter of 2027; either party may terminate if not closed by June 17, 2027; termination fees are $300,000 (Aethlon) and $2,000,000 (North Immunology) in specified cases
Combined company expected to trade on Nasdaq Capital Market under ticker NRTX and be led by North Immunology's CEO
Fortitude Mining Holdings, the business HeartSciences has agreed to combine with under a June 23, 2026 merger agreement, appointed Jaime Leverton as its Chief Executive Officer and a board member, effective September 21, 2026. Andrea Childs resigned from the Fortitude board and will step down as CEO on that date to become Chief Operating Officer. The filing says Leverton is expected to lead the combined company after the deal closes, which is expected in the fourth quarter of 2026 subject to HeartSciences shareholder approval.
Jaime Leverton becomes CEO and a director of Fortitude effective September 21, 2026; she previously served as CEO of Hut 8 and most recently led ReserveOne.
Andrea Childs resigns from the Fortitude board effective immediately and becomes Chief Operating Officer on September 21, 2026.
The merger agreement was signed June 23, 2026; closing is expected in the fourth quarter of 2026, subject to HeartSciences shareholder approval.
Fortitude reported second quarter revenue of $20.9 million, according to the press release furnished as Exhibit 99.1.
StablecoinX Inc. and its subsidiary signed a Waiver Letter with Ethena OpCo Ltd. and the Ethena Foundation on September 14, 2026. The Ethena Parties agreed to permanently release lock-up restrictions on the company's ENA tokens, effective October 5, 2026, and the letter sets a framework for the company to sell ENA tokens to fund working capital, subject to notice and Foundation consent rights.
Waiver Letter dated September 14, 2026, effective October 5, 2026, covers all lock-up, vesting and unlocking restrictions on the company's ENA tokens, including a 48-month contractual lock-up tied to the PIPE in connection with its business
Any Funding Sale requires at least five business days' prior written notice, giving the Foundation the option to acquire all or part of the ENA at the proposed price.
Any ENA sale still requires Foundation consent, not to be unreasonably withheld, under Section 4.2(b) of the Collaboration Agreement dated September 5, 2025; applicable law restrictions remain in effect.
Dominari Holdings Inc. (Nasdaq: DOMH) said its board on September 16, 2026 authorized a share repurchase program of up to $5 million of its common stock. The buyback may be executed through open-market transactions under Rule 10b5-1 and Rule 10b-18, and the board may terminate the authorization at any time.
Authorized amount: up to $5 million aggregate purchase price
Board authorization date: September 16, 2026; announced September 17, 2026
Repurchases to be made via open-market transactions under Rules 10b5-1 and 10b-18; timing and amount depend on market, business and blackout conditions
CEO Anthony Hayes cited a strong balance sheet headed into year-end
Atlanticus Holdings completed the sale of its CAR Auto Finance operations, which made up its entire Auto Finance segment, to an unaffiliated third party. Total consideration is approximately $71.2 million, including $56.2 million in cash and a $15.0 million seller note. The company says the cash proceeds will be used to reduce debt and invest in higher-growth product lines, but the filing does not disclose the sale's effect on earnings.
Total consideration of approximately $71.2 million: $56.2 million in cash and a $15.0 million seller note
CAR comprised 100% of the Auto Finance segment, which Atlanticus will no longer operate
Approximately 154 team members associated with CAR are transitioning to the buyer
Company expects to use cash proceeds to reduce debt and invest in higher-growth product lines
Ispire reported fiscal fourth-quarter revenue of $26.7 million, up 33% from a year earlier, and a net loss of $13.8 million ($0.24 per share), versus $14.8 million a year ago. For fiscal 2026, revenue fell 24.7% to $96.0 million, though the net loss narrowed to $33.2 million, and the company said the timing of reaching positive cash flow is now less certain because of Malaysia facility investments.
Q4 revenue $26.7 million vs. $20.1 million a year earlier; gross margin 6.3% vs. 12.3%, hit by inventory impairments
Fiscal 2026 revenue $96.0 million vs. $127.5 million; net loss $33.2 million ($0.58 per share) vs. $39.2 million
Company previously expected positive cash flow in the second half of calendar 2026; it now says timing is less certain
Cash of $19.3 million at June 30, 2026; total stockholders' deficit of $29.2 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.